The BA.3.2 variant of COVID-19, also known as the Cicada variant, was first identified in South Africa in November 2024 and has since spread to at least 23 countries, including 25 states in the U.S. The variant carries approximately 70-75 mutations in the spike protein, raising concerns about its ability to evade immunity from prior infections and current vaccines.

Health experts are closely monitoring the situation. Brandon Dionne noted, “There definitely are quite a few mutations with this one, so there’s concern that the current vaccine is not going to be a great match.” Symptoms associated with BA.3.2 include sore throat, cough, congestion, fatigue, headache, fever, nausea, and diarrhea.

As of now, the CDC and WHO are actively tracking the variant’s spread. In the U.S., BA.3.2 was first detected in June 2025, and current vaccines are expected to provide some level of protection against it, although the exact effectiveness remains uncertain. Dr. Adolfo García-Sastre commented, “It’s not completely clear how effective the current vaccine will be, but it likely still has some effectiveness.”

Despite the alarming number of mutations, Andrew Pekosz stated, “It looks scary on paper, but it hasn’t really made a big impact in terms of disease in most places yet.” However, the variant’s emergence coincides with a troubling trend in the U.S., where COVID-19 is linked to 300-500 deaths per week.

Neil Maniar emphasized the importance of protecting high-risk individuals and continuing standard precautions, stating, “The biggest focus is really on protecting higher risk individuals and continuing standard precautions.”

Currently, 11 percent of wastewater samples in the U.S. contain BA.3.2, indicating its presence in communities. However, the exact prevalence of the variant remains unclear due to reduced surveillance efforts.

As health officials continue to monitor BA.3.2, uncertainties linger regarding its potential to evolve further and whether it will trigger a surge in cases. Details remain unconfirmed.

Сообщение Covid 19 cicada variant: COVID-19 Cicada Variant BA.3.2 Emerges in South Africa появились сначала на justrealnews.

The COVID variant BA.3.2, known as Cicada, is causing rising cases in the U.S. and globally, raising alarms among health officials. The variant, first detected in a traveler to the United States in June 2025, has since spread rapidly, with the first U.S. case diagnosed in January 2026.

As of February 11, 2026, BA.3.2 has been reported in at least 25 states across the U.S. and is responsible for approximately 30% of COVID-19 sequences in Germany and some Northern European countries. The World Health Organization classified BA.3.2 as a ‘variant under monitoring’ in December 2025, highlighting its potential impact.

BA.3.2 is characterized by a highly mutated spike protein, with 70-75 mutations identified. This raises concerns about its ability to evade immunity from previous infections or vaccinations. According to the CDC, “Monitoring the spread of BA.3.2 provides valuable information about the potential for this new SARS-CoV-2 lineage to evade immunity from a previous infection or vaccination.”

In the U.S., BA.3.2 has been detected in 3.7% of wastewater samples as of March 14, 2026, indicating its prevalence in communities. The variant has been reported in at least 23 countries, underscoring its global reach.

Despite the alarming statistics, experts like Dr. Andrew Pekosz emphasize that while BA.3.2 looks concerning on paper, it has not yet significantly impacted disease severity in most regions. However, Dr. Robert H. Hopkins, Jr. warns that low vaccination rates and insufficient public health measures leave the population vulnerable.

Current COVID vaccines are expected to continue providing protection against severe disease from BA.3.2, but the effectiveness of these vaccines against the variant is still being studied. As the situation evolves, health officials urge continued vigilance and vaccination efforts.

Details remain unconfirmed regarding the potential for BA.3.2 to cause a surge in cases in the U.S. Further developments are anticipated as researchers and health authorities monitor the variant closely.

Сообщение Cicada COVID Variant Causes Surge in Cases Across the U.S. появились сначала на justrealnews.